Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Semaglutide Health Outcomes and Patient Adherence on Digital Health Platforms in Australia (SHAPED-AU)

NCT07881770 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT07881770
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07881770 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Semaglutide Health Outcomes and Patient Adherence on Digital Health Platforms in Australia (SHAPED-AU)
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Not yet recruiting
Start date
October 13, 2026
Completion date
February 28, 2028
Enrollment
10,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, overweight